Fundraising Fox
ProPhase Labs
OTC: PRPHUniondale, US · Delaware corporation · 46 employees on LinkedIn
Find your way into ProPhase Labs
35 people in our graph can introduce you to the ProPhase Labs team.
Sign up to see every warm intro you have to ProPhase Labs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ProPhase Labs team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ProPhase Labs appears to operate multiple subsidiary companies including Nebula Genomics, ProPhase Biopharma, and TK Supplements, but detailed information about the company's primary business, products, and market focus is not available on this investor relations presentations page.
Founders & leadership
KL
Kevin LeeCo-founder of Nebula Genomics
GC
George ChurchCo-founder of Nebula Genomics
TK
Ted KarkusCEO and ChairmanHe previously led ID Biomedical (sold to GlaxoSmithKline for $1.4 billion) and served as CEO of ProPhase Labs' predecessor, overseeing the Cold-EEZE product line before its sale to Mylan.
RV
Robert V. Cuddihy, Jr.Executive
Board
CA
CAROLINA ABENANTEBoard director
WH
WARREN HIRSCHBoard director
LG
LOUIS GECKELBoard director
LG
Louis GleckelBoard director
JM
James McCubbinBoard director
MB
Mark BurnettBoard director
JB
Jason BarrBoard director
ML
Mark LeventhalBoard director
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 3 rounds · 2015–2025
▶$3MraisedAug 2025 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedAug 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- LOUIS GECKELDirector
- WARREN HIRSCHDirector
- CAROLINA ABENANTEDirector
- TED KARKUSExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $3M
- Minimum investment
- $500K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedJul 2025 · 2 investors · BiotechnologyRule 506(b)
▶$1MraisedJul 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- CAROLINA ABENANTEDirector
- WARREN HIRSCHDirector
- LOUIS GECKELDirector
- TED KARKUSExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $500K
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedDec 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedDec 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Louis GleckelDirector
- Robert V. Cuddihy, Jr.Executive Officer
- James McCubbinDirector
- Mark BurnettDirector
- Jason BarrDirector
- Mark LeventhalDirector
- Ted KarkusExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.5M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies working in the same space as ProPhase Labs.
Frequently asked questions
- What does ProPhase Labs do?
- ProPhase Labs appears to operate multiple subsidiary companies including Nebula Genomics, ProPhase Biopharma, and TK Supplements, but detailed information about the company's primary business, products, and market focus is not available on this investor relations presentations page.
- Who founded ProPhase Labs?
- ProPhase Labs was founded by Kevin Lee, George Church.
- How much funding has ProPhase Labs raised?
- ProPhase Labs has disclosed $5.5M raised across 3 rounds.
- Where is ProPhase Labs headquartered?
- ProPhase Labs is headquartered in Uniondale, US.